|
|
|
|
| LEADER |
05303nam a2200481 4500 |
| 001 |
ocn913622153 |
| 003 |
OCoLC |
| 005 |
20180501122023.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
141213s2014 vtu o 000 0 eng d |
| 040 |
|
|
|a CNCGM
|b eng
|e pn
|c CNCGM
|d OCLCO
|d EBLCP
|d N$T
|d OPELS
|d YDXCP
|d OCLCF
|d OPELS
|d OCLCQ
|d SAV
|d OCLCQ
|d OCLCO
|d GrThAP
|
| 019 |
|
|
|a 898101576
|a 899277710
|
| 020 |
|
|
|a 9780444633910
|q (electronic bk.)
|
| 020 |
|
|
|a 044463391X
|q (electronic bk.)
|
| 020 |
|
|
|a 9780444634078
|
| 035 |
|
|
|a (OCoLC)913622153
|z (OCoLC)898101576
|z (OCoLC)899277710
|
| 050 |
|
4 |
|a RM302.5
|b .S53 2014
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.704
|a 615/.704
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Side Effects of Drugs Annual :
|b a worldwide yearly survey of new data in adverse drug reactions.
|n Vol. 36 /
|c editor Sidhartha D. Ray.
|
| 260 |
|
|
|a Burlington :
|b Elsevier Science,
|c 2014.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 500 |
|
|
|a Seda-35, 183].
|
| 505 |
0 |
|
|a Front Cover; SIDE EFFECTS OF DRUGS ANNUAL; Copyright; Contributors; Contents; Preface; Special Reviews in SEDA-36; Table of Essays, Annuals 1-35; Mechanistic and Clinical Descriptions of Adverse Drug Reactions; EIDOS; DOTS; References; Definitive (Between-the-Eyes) Adverse Drug Reactions; References; How to Use This Book; THE SCOPE OF THE SIDE EFFECTS OF DRUGS ANNUALS; ALLOCATION OF DRUGS TO CHAPTERS; Abbreviations; Classification of Immunological Reactions; OTHER TYPES OF REACTIONS; References; Classification of Drug Teratogenicity; References; Grades of Adverse Drug Reactions; References.
|
| 505 |
8 |
|
|a Chapter 1 -- Central Nervous System Stimulants and Drugs that Suppress AppetiteAMPHETAMINE AND AMPHETAMINE DERIVATES [SEDA-15, 180; SEDA-32, 1; SEDA-33, 1; SEDA-34, 1]; METHYLPHENIDATE [SEDA-15, 2307; SEDA-32, 10; SEDA-33, 7; SEDA-34, 5]; METHYLXANTHINES; SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITORS ATOMOXETINE [SEDA-33, 6; SEDA-34, 4]; VIGILANCE PROMOTING DRUGS; DRUGS THAT SUPPRESS APPETITE [SEDA-30, 7; SEDA-32, 16; SEDA-33, 13; SEDA-34, 8]; PARASYMPATHOMIMETICS [SEDA-32, 19; SEDA-33, 15; SEDA-34, 9]; References; Chapter 2 -- Antidepressant Drugs; GENERAL.
|
| 505 |
8 |
|
|a SELECTIVE SEROTONIN REUPTAKE INHIBITORS [SED-15, 3109 SEDA-31, 18; SEDA-32, 33; SEDA-33, 26; SEDA-34, 17; SEDA-35, 30]; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS; TRICYCLIC ANTIDEPRESSANTS; OTHER ANTIDEPRESSANTS; References; Chapter 3 -- Lithium; LITHIUM TOXICITY; References; Chapter 4 -- Drugs of Abuse; CANNABINOIDS; COCAINE; ECSTASY (3,4-METHYLENEDIOXYMETAMFETAMINE); References; Chapter 5 -- Hypnosedatives and Anxiolytics; BENZODIAZEPINES [SED-15, 429; SEDA-31, 57; SEDA-32, 75; SEDA-33, 71; SEDA-34, 45]; HYPNOSEDATIVES AND BENZODIAZEPINE-LIKE DRUGS [SED-15, 3710; SEDA-33, 78.
|
| 505 |
8 |
|
|a SEDA-34, 47]References; Chapter 6 -- Antipsychotic Drugs; GENERAL [SED-15, 2438; SEDA-32, 83; SEDA-33, 89; SEDA-34, 51; SEDA-35, 85]; INDIVIDUAL DRUGS; References; Chapter 7 -- Antiepileptic Drugs; RX PHARMACOGENOMICS AND ANTIEPILEPTIC MEDICATIONS; GENERAL; COMPARATIVE STUDIES; ETHOSUXIMIDE; References; Chapter 8 -- Opioid Analgesics and Narcotic Antagonists; RX: OPIOID ABUSE EPIDEMIC AND THE ROLE OF TAKE-HOME NALOXONE; ALFENTANIL [SED-15, 72; SEDA-33, 209; SEDA-34, 152; SEDA-35, 173]; CODEINE [SED-15, 880; SEDA-33, 209; SEDA-34, 152; SEDA-35, 174]; DEXTROMETROPHAN [SED-15, 1088.
|
| 505 |
8 |
|
|a Seda-33, 210 seda-34, 153; seda-35, 174]; diamorphine [sed-15, 1096; seda-33, 210; seda-34, 153; seda-35, 175]; dihydrocodeine [sed-15, 1125; seda-33, 211; seda-34, 154; seda-35, 175]; fentanyl [sed-15, 1346; seda-33, 211; seda-34, 154; seda-35, 176]; hydrocodone [sed-15, 1702; seda-34, 156; seda-35, 177]; methadone [sed-15, 2270; seda-33, 214; seda-34, 157; seda-35, 177]; morphine [sed-15, 2386; seda-33, 216; seda-34, 159; seda-35, 181]; oxycodone [sed-15, 2651; seda-33, 219; seda-34, 161; seda-35, 182]; papaverine [sed-15, 2678; seda-33, 221; seda-34, 162.
|
| 520 |
|
|
|a The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading. Provides a critical yearly survey of new data and trends on the.
|
| 650 |
|
0 |
|a Drugs
|x Side effects.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drugs
|x Side effects.
|2 fast
|0 (OCoLC)fst00898912
|
| 650 |
|
2 |
|a Drug-Related Side Effects and Adverse Reactions.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Ray, Sidhartha D.
|
| 776 |
0 |
8 |
|i Print version:
|a Ray, Sidhartha D.
|t Side Effects of Drugs Annual : A worldwide yearly survey of new data in adverse drug reactions.
|d Burlington : Elsevier Science, ©2014
|z 9780444634078
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/03786080/36
|z Full Text via HEAL-Link
|
